Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a new revision tag (v3.7.0) and a large set of study-related terms and keywords were removed, indicating a restructuring of the trial's metadata and indexing.SummaryDifference17%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision changed from v3.6.5 to v3.6.6 on the page, indicating a newer build/version. No visible content changes are inferred from this update.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating a newer version of the content. This change reflects an update to the page's revision history rather than to the study details or user-facing information.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4. This represents a minor update to the Study Details page on ClinicalTrials.gov, likely reflecting updated metadata or formatting.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.2 was removed, indicating an updated revision state for the study record.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision. This change does not affect the visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.